Mpox, formerly known as monkeypox, is a viral zoonotic disease caused by the monkeypox virus. Traditionally found in Central and West Africa, Mpox has recently spread to other regions, including Afghanistan, due to increased global travel and connectivity. This guide provides crucial information on the occurrence of Mpox in Afghanistan, its prevention, symptoms, risks, and available treatment options to help protect public health.
Overview
Mpox is an infectious disease that can cause painful rashes, swollen lymph nodes, fever, headache, muscle aches, back pain, and fatigue. Most people recover fully, but some may become severely ill.
Mpox is caused by the monkeypox virus (MPXV). It is an enveloped double-stranded DNA virus of the Orthopoxvirus genus in the Poxviridae family, which includes other viruses such as variola, cowpox, and vaccinia.
The natural reservoir of the virus is unknown, but various small mammals such as squirrels and monkeys are susceptible to the virus.
Key Facts
- Mpox is caused by the monkeypox virus, which belongs to the Orthopoxvirus genus.
- Mpox remains a significant global health concern, with recent surges in cases in the Democratic Republic of the Congo and other regions, particularly from clades Ia and Ib.
- Vaccines are available for Mpox and should be considered alongside other public health measures.
- Common symptoms include a skin rash or mucosal lesions that last 2–4 weeks, accompanied by fever, headache, muscle aches, back pain, low energy, and swollen lymph nodes.
- Mpox spreads through close contact with an infected person, contaminated materials, or animals. During pregnancy, the virus can be passed to the fetus or newborn.
- Mpox treatment focuses on managing symptoms like pain and fever, along with ensuring proper nutrition, hydration, skin care, and preventing secondary infections.
Mpox in Afghanistan
It appears that the first cases of Mpox have been identified in Afghanistan. Initial results show that three patients from Paktia, Nangarhar, and Kabul have been diagnosed with the disease. Given the limited healthcare services in the country, families are expected to exercise extreme caution in preventing infection.
Reports indicate that three suspected cases of Mpox have been recorded in Kabul, Nangarhar, and Paktia. In Kabul, a young girl with symptoms of Mpox has been admitted to the children's hospital. Doctors state that a child from Farza district of Kabul, suspected of having Mpox, visited the hospital on August 26, 2024. Sources in Paktia also report that on August 26, 2024, a suspected case of Mpox was registered at Kausar Hospital, and this child is a boy.
A suspected Mpox case has also been reported by the regional hospital in Jalalabad city, Nangarhar province. The child is a girl from Qarghai district of Laghman province, presenting with vesicular lesions on both forearms.
The Ministry of Public Health of the Taliban has not made any statements regarding this issue so far. It is unclear whether the suspected Mpox cases were within the country or came from abroad. Cases of Mpox have also been recorded in Pakistan and Iran, where millions of Afghan immigrants live and travel between these countries and Afghanistan.
Although Mpox is not endemic to Afghanistan, the country is not immune to its emergence. The recent global spread of the disease has led to increased awareness and surveillance. In Afghanistan, the occurrence of Mpox may be underreported due to limited healthcare infrastructure and diagnostic capabilities. The presence of international travel routes and the movement of people across borders have increased the risk of Mpox being introduced into the country.
Transmission of Mpox
Mpox primarily spreads through close contact with an infected person, including direct skin-to-skin contact, sexual contact, or respiratory droplets during face-to-face interaction. The virus can also be transmitted through contaminated objects, such as clothing or bedding, and from infected animals to humans. Pregnant women can pass the virus to their fetus during pregnancy or to their newborn during childbirth.
Animal-to-human transmission occurs through bites, scratches, or activities like hunting, skinning, and cooking infected animals. The exact animal reservoir for the monkeypox virus remains unknown, and further research is ongoing to understand the full transmission dynamics.
Symptoms and Signs
Mpox presents symptoms and signs that typically begin within a week, but can appear between 1 to 21 days after exposure. Symptoms generally last 2 to 4 weeks but may persist longer in individuals with weakened immune systems.
Common symptoms of Mpox include:
- Skin rash
- Fever
- Sore throat
- Headache
- Muscle aches
- Back pain
- Fatigue
- Swollen lymph nodes
For some individuals, the first sign of Mpox may be a rash, while others might initially experience fever, muscle pain, or a sore throat. The Mpox rash usually starts on the face and spreads to the body, including the palms of the hands and soles of the feet. It may also appear in other areas with more direct contact with the virus, such as the mouth, throat, genital area, and anus. In some cases, Mpox rashes can develop into red, raised lesions that may turn into blisters. If severe symptoms such as skin infections, intense pain, severe lymph node swelling, or lesions in the eyes or mouth occur, seek medical attention immediately.
Individuals experiencing symptoms and signs of Mpox should contact healthcare providers.
Diagnosis of Mpox
Diagnosing Mpox can be challenging due to its similarity to other conditions like chickenpox, measles, and sexually transmitted infections. Laboratory testing, particularly PCR testing of lesions, is crucial for accurate diagnosis. Healthcare providers should also consider testing for HIV and other co-infections, as these can complicate the clinical picture and impact treatment.
Treatment and Vaccination for Mpox
Treatment for Mpox is primarily supportive, focusing on relieving symptoms, preventing complications, and ensuring proper wound care. Key aspects of treatment include:
- Symptomatic Relief: Pain relievers, hydration, and antihistamines for itching are commonly used. Proper care of skin lesions is essential to prevent secondary infections.
- Antiviral Medications: While no specific antiviral treatment for Mpox is approved, medications like tecovirimat may be considered in severe cases.
- Isolation: Infected individuals should isolate to prevent spreading the virus, ideally staying in a separate room and avoiding contact with others.
- Hospitalization: Severe cases may require hospitalization, particularly if complications like respiratory distress or encephalitis develop.
Vaccination is recommended for high-risk individuals, including healthcare workers and those with potential exposure to the virus. Although there is no specific Mpox vaccine, the smallpox vaccine offers some protection. Vaccination can also be administered after exposure to reduce the severity of the disease.
Self-care and Prevention of Mpox
Preventing Mpox involves personal hygiene, public health measures, and vaccination. To reduce the risk of transmission:
- Avoid Contact: Stay away from infected individuals and animals, especially those showing signs of illness.
- Practice Good Hygiene: Regular handwashing and using alcohol-based sanitizers can help prevent transmission.
- Use PPE: Healthcare workers and caregivers should use appropriate personal protective equipment when caring for Mpox patients.
- Public Awareness: Educating the community about Mpox risks and prevention is essential to curb the spread of the disease.
Risks and Complications of Mpox
Mpox can have serious health implications, particularly for vulnerable populations:
- Children: Young children are at higher risk of severe illness due to their developing immune systems.
- Pregnant Women: Mpox can be transmitted to the fetus, leading to pregnancy complications or neonatal infection.
- Immunocompromised Individuals: Those with weakened immune systems, such as HIV/AIDS patients, are more susceptible to severe Mpox complications.
- Healthcare Workers: Due to close contact with infected patients, healthcare workers are at increased risk, particularly without proper protective measures.
Complications of Mpox can include secondary infections, respiratory distress, sepsis, encephalitis, and, in severe cases, death. The case fatality rate varies between 1% and 10%, depending on the virus strain and the patient’s overall health.
Conclusion
Mpox is a significant public health concern that requires ongoing vigilance and preparedness in Afghanistan. Understanding the symptoms, risks, prevention strategies, and treatment options is crucial for protecting yourself and your community. Public awareness, early detection, and timely intervention are key to mitigating the impact of Mpox in Afghanistan. By staying informed and taking appropriate preventive measures, we can reduce the spread of Mpox and safeguard public health.
Stigma and discrimination associated with Mpox, especially towards vulnerable communities, can hinder public health efforts. It’s essential to address and counteract stigma to encourage people to seek care and prevent further spread of the disease.
Ask for help from "Beporsed"
For those Afghans seeking specific information, "Beporsed" is here to help. You can reach our information center through WhatsApp (+93729807235), Facebook Messenger, or our website's Messenger to ask our online information desk officer for assistance.
For more information
For more information on immigration, resettlement, education and scholarship programs, and other opportunities available to Afghans worldwide, as well as details on the humanitarian services provided by international organizations in Afghanistan and procedures for obtaining civil documents from governmental institutions, please visit Beporsed's website and social media pages.
• WhatsApp Channel-Beporsed